Your browser doesn't support javascript.
loading
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita, Jolien M; van Harten, Wim H; Retel, Valesca P; van 't Veer, Laura J; van Dam, Frits Sam; Karsenberg, Kim; Douma, Kirsten Fl; van Tinteren, Harm; Peterse, Johannes L; Wesseling, Jelle; Wu, Tin S; Atsma, Douwe; Rutgers, Emiel Jt; Brink, Guido; Floore, Arno N; Glas, Annuska M; Roumen, Rudi Mh; Bellot, Frank E; van Krimpen, Cees; Rodenhuis, Sjoerd; van de Vijver, Marc J; Linn, Sabine C.
Afiliación
  • Bueno-de-Mesquita JM; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Harten WH; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van 't Veer LJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Agendia, Amsterdam, Netherlands.
  • van Dam FS; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Karsenberg K; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Douma KF; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Tinteren H; Biometric Department, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Peterse JL; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Wesseling J; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Wu TS; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Atsma D; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Rutgers EJ; Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Brink G; Agendia, Amsterdam, Netherlands.
  • Floore AN; Agendia, Amsterdam, Netherlands.
  • Glas AM; Agendia, Amsterdam, Netherlands.
  • Roumen RM; Department of Surgery, Maxima Medical Centre, Eindhoven, Netherlands.
  • Bellot FE; Department of Pathology, Spaarne Hospital, Hoofddorp, Netherlands.
  • van Krimpen C; Department of Pathology, Reinier de Graaf Hospital, Delft, Netherlands.
  • Rodenhuis S; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van de Vijver MJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Academic Medical Centre, Amsterdam, Netherlands.
  • Linn SC; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: s.linn@nki.nl.
Lancet Oncol ; 8(12): 1079-1087, 2007 Dec.
Article en En | MEDLINE | ID: mdl-18042430
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Pruebas Genéticas / Selección de Paciente / Análisis de Secuencia por Matrices de Oligonucleótidos / Perfilación de la Expresión Génica / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Pruebas Genéticas / Selección de Paciente / Análisis de Secuencia por Matrices de Oligonucleótidos / Perfilación de la Expresión Génica / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido